Viking Therapeutics Surges on Obesity Data, Pressures Rivals
Viking Therapeutics (NASDAQ: VKTX) shares rose sharply after mid-stage trial data showed its obesity drug held on to most of its weight-loss effect with less frequent dosing, pressuring incumbents Eli…